Contracts › 75N94025F00001
75N94025F00001: Nichd: R&D: Essential Studies and Manufacture for Current Products in Ongoing Clinical Development: Non-Severable
Awarded to Sri International by National Institutes of Health (NIH).
$1.2Mobligated
$1.2Mpotential value
01 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94025F00001 |
|---|---|
| Vehicle | 75N94020D00003 |
| Awardee | Sri International |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | CA |
| Period of performance | 02 June 2025 to 01 June 2027 |
| Potential end | 01 June 2027 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 04 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record